Search research articles
Contact Us
Filters
Showing results (301-310 of 738) with videos related to
Page
of 74
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 14, 2000
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
W A Peters, P Y Liu, R J Barrett, et al.
Gynecologic Oncology
|
December 11, 2012
Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: a Gynecologic Oncology Group Study
Bradley J Monk, Helen Q Huang, Robert A Burger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 21, 2024
Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations
Daniel L Hertz, Markus Joerger, Yung-Jue Bang, et al.
Gynecologic Oncology
|
July 7, 2012
Patient-reported outcomes in relapsed ovarian cancer: results from a randomized Phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD alone
Carolyn N Krasner, Andres Poveda, Thomas J Herzog, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 24, 2015
Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study
Ramez N Eskander, Shamshad Ali, Thanh Dellinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2023
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
William A Peters, P Y Liu, Rolland J Barrett, et al.
Gynecologic Oncology
|
June 21, 2018
A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254)
John K Chan, William Brady, Bradley J Monk, et al.
Cancer
|
March 10, 2001
Primary invasive carcinoma of the vagina: treatment with interstitial brachytherapy
K S Tewari, F Cappuccini, A A Puthawala, et al.
Gynecologic Oncology
|
July 22, 2017
A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study
John K Chan, Wei Deng, Robert V Higgins, et al.
Gynecologic Oncology
|
February 18, 1999
Phase II trial of vinorelbine in recurrent and progressive epithelial ovarian cancer
R A Burger, P J DiSaia, J A Roberts, et al.
Page
of 74
Search research articles
Search
Showing results (301-310 of 738) with videos related to
Sort By:
Page
of 74
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 14, 2000
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
W A Peters, P Y Liu, R J Barrett, et al.
Gynecologic Oncology
|
December 11, 2012
Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: a Gynecologic Oncology Group Study
Bradley J Monk, Helen Q Huang, Robert A Burger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 21, 2024
Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations
Daniel L Hertz, Markus Joerger, Yung-Jue Bang, et al.
Gynecologic Oncology
|
July 7, 2012
Patient-reported outcomes in relapsed ovarian cancer: results from a randomized Phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD alone
Carolyn N Krasner, Andres Poveda, Thomas J Herzog, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 24, 2015
Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study
Ramez N Eskander, Shamshad Ali, Thanh Dellinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2023
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
William A Peters, P Y Liu, Rolland J Barrett, et al.
Gynecologic Oncology
|
June 21, 2018
A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254)
John K Chan, William Brady, Bradley J Monk, et al.
Cancer
|
March 10, 2001
Primary invasive carcinoma of the vagina: treatment with interstitial brachytherapy
K S Tewari, F Cappuccini, A A Puthawala, et al.
Gynecologic Oncology
|
July 22, 2017
A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study
John K Chan, Wei Deng, Robert V Higgins, et al.
Gynecologic Oncology
|
February 18, 1999
Phase II trial of vinorelbine in recurrent and progressive epithelial ovarian cancer
R A Burger, P J DiSaia, J A Roberts, et al.
Page
of 74